Literature DB >> 11162078

Detection of embB codon 306 mutations in ethambutol resistant Mycobacterium tuberculosis directly from sputum samples: a low-cost, rapid approach.

H Rinder1, K T Mieskes, E Tortoli, E Richter, M Casal, M Vaquero, E Cambau, K Feldmann, T Löscher.   

Abstract

Substitutions of codon 306 in the gene embB are the most common mutations found in ethambutol resistant Mycobacterium tuberculosis. The characterization of these mutations has been hampered by the need for prior cultivation of the mycobacteria, or the need for DNA sequencing, or both. Here, we describe a simple and culture-independent technique to detect embB codon 306 mutations directly from sputum samples, requiring little more than a PCR machine and a simple agarose minigel. There is no need for labelled probes or DNA sequencing. In a preliminary test of feasibility, interpretable results were obtained from 21 of 24 selected sputum samples, 12 of which were determined to contain ethambutol resistant M. tuberculosis after culture. All of six samples with embB codon 306 mutations were correctly identified. Although an exact validation of this technique is beyond the scope of this technical report, we conclude from well-known embB codon 306 mutation prevalence figures that approximately one half of EMB resistant cases could already be predicted within 2 working days, with little equipment or hands-on time needed, instead of weeks required for conventional resistance testing. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162078     DOI: 10.1006/mcpr.2000.0339

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  12 in total

Review 1.  Evolution of drug resistance in Mycobacterium tuberculosis: clinical and molecular perspective.

Authors:  Stephen H Gillespie
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis.

Authors:  Ann S G Lee; Siti Noor Khadijah Othman; Yu Min Ho; Sin Yew Wong
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

3.  Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.

Authors:  Ruiru Shi; Jianyuan Zhang; Koji Otomo; Guolong Zhang; Isamu Sugawara
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

4.  Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance.

Authors:  Manzour Hernando Hazbón; Miriam Bobadilla del Valle; Marta Inírida Guerrero; Mandira Varma-Basil; Ingrid Filliol; Magali Cavatore; Roberto Colangeli; Hassan Safi; Helen Billman-Jacobe; Caroline Lavender; Janet Fyfe; Lourdes García-García; Amy Davidow; Michael Brimacombe; Clara Inés León; Tania Porras; Mridula Bose; Fernando Chaves; Kathleen D Eisenach; José Sifuentes-Osornio; Alfredo Ponce de León; M Donald Cave; David Alland
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

5.  Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.

Authors:  Linda M Parsons; Max Salfinger; Anne Clobridge; Jillian Dormandy; Lisa Mirabello; Valerie L Polletta; Ahmet Sanic; Oleg Sinyavskiy; Susan C Larsen; Jeffrey Driscoll; Genet Zickas; Harry W Taber
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

6.  Direct detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis in auramine-rhodamine-positive sputum specimens by real-time PCR.

Authors:  Maite Ruiz; Maria J Torres; Ana C Llanos; Aurelio Arroyo; Jose C Palomares; Javier Aznar
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

7.  Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis.

Authors:  Angela M Starks; Aysel Gumusboga; Bonnie B Plikaytis; Thomas M Shinnick; James E Posey
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

8.  Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis.

Authors:  Hassan Safi; Robert D Fleischmann; Scott N Peterson; Marcus B Jones; Behnam Jarrahi; David Alland
Journal:  Antimicrob Agents Chemother       Date:  2009-10-12       Impact factor: 5.191

9.  Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin.

Authors:  Hassan Safi; Brendan Sayers; Manzour H Hazbón; David Alland
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

10.  Evaluation of FLASH - PCR forrapid detection of Mycobacterium tuberculosis from clinical specimens.

Authors:  Abbas Ali Imani Fooladi; Yousef Tarvedi Zadeh; Rezvan Mehrab; Raheleh Halabian; Taghi Azizi
Journal:  Iran J Microbiol       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.